Aldeyra Therapeutics (ALDX) Capital Expenditures (2014 - 2022)
Aldeyra Therapeutics (ALDX) posted Capital Expenditures of $16317.0 for Q1 2022, up 109.03% on a QoQ basis from $7806.0 in Q1 2021, and up 109.03% year-over-year from $7806.0 in Q1 2021.
Aldeyra Therapeutics (ALDX) Capital Expenditures (2014 - 2022) Analysis & Trends
Aldeyra Therapeutics' Capital Expenditures history runs 8 years deep, the most recent figure standing at $16317.0 for Q1 2022.
- Quarterly Capital Expenditures rose 109.03% year-over-year to $16317.0 in Q1 2022, while the trailing twelve-month figure through Dec 2022 was $16317.0 (up 109.03% YoY) and the FY2022 annual result came in at $16317.0, up 109.03% from the prior year.
- Capital Expenditures was $16317.0 for Q1 2022 at Aldeyra Therapeutics, up from $7806.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $139006.0 in Q1 2018 and bottomed at $4604.0 in Q2 2019.
- A 4-year average of $37077.2 and a median of $15450.5 in 2018 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2018 — Capital Expenditures soared 1099.15% — and 2019, when it slumped 96.46%.
- Aldeyra Therapeutics' Capital Expenditures stood at $14584.0 in 2018, then tumbled by 68.43% to $4604.0 in 2019, then soared by 69.55% to $7806.0 in 2021, then jumped by 109.03% to $16317.0 in 2022.
- Business Quant data shows ALDX's Capital Expenditures at $16317.0 in Q1 2022, $7806.0 in Q1 2021, and $4604.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 43.25 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 786,000.00 |
| 10 | Aldeyra Therapeutics | 95.00 Mn | 95.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 16,317.00 |
| Mar 31, 2022 | 16,317.00 |
| Mar 31, 2021 | 7,806.00 |
| Mar 31, 2021 | 7,806.00 |
| Jun 30, 2019 | 4,604.00 |
| Jun 30, 2019 | 4,604.00 |
| Mar 31, 2019 | 4,925.00 |
| Mar 31, 2019 | 4,925.00 |
| Dec 31, 2018 | 14,584.00 |
| Dec 31, 2018 | 14,584.00 |
| Sep 30, 2018 | 47,619.00 |
| Sep 30, 2018 | 47,619.00 |
| Jun 30, 2018 | 61,757.00 |
| Jun 30, 2018 | 61,757.00 |
| Mar 31, 2018 | 139,006.00 |
| Mar 31, 2018 | 139,006.00 |
| Dec 31, 2017 | 13,167.00 |
| Dec 31, 2017 | 13,167.00 |
| Mar 31, 2017 | 11,592.00 |
| Mar 31, 2017 | 11,592.00 |